New Jersey Urology

Recent papers from New Jersey Urology

1. Role of Non‐Thermal Processing Technologies in Modulating Protein Allergenicity in LegumesFood Science & Nutrition · 2026
2. Interventional, multicentre investigation of a novel lumbar total joint replacement: propensity matched study design and protocolBMJ Open · 2026
3. Abstract 3685: A case of rapid progression from Stage I to Stage IV in an MSI-H/EMAST African American colorectal patientCancer Research · 2026
4. Real-world clinical outcomes among patients with localized prostate cancer (LPC) undergoing radical prostatectomy (RP).Journal of Clinical Oncology · 2026
5. Real-world comparison of prostate-specific antigen (PSA) response in metastatic castration-sensitive prostate cancer (mCSPC) patients treated with apalutamide (APA) without docetaxel vs darolutamide (DARO) without docetaxel.Journal of Clinical Oncology · 2026
6. Impact of piflufolastat F18 imaging on disease management for prostate cancer patients: Observations from the PYLARIFY Registry study.Journal of Clinical Oncology · 2026
7. Homologous Recombination Repair Mutations, Next-generation Sequencing Testing, and Treatment Progression by Race Among Patients With Metastatic Castration-sensitive Prostate CancerUrology · 2026
8. Roles of Cold Plasma Treatment on the Functional Properties of Plant‐Based ProteinsInternational Journal of Food Science · 2026
9. Radiation Exposure, Knowledge, and Compliance in Upper Tract Urological Surgery: A Systematic ReviewCureus · 2025
10. Progressive arachnoiditis following spine surgery: a case reportInterdisciplinary Neurosurgery · 2025
11. Comparison of Real-World Outcomes between Patients with BRCA1/2-Positive and Homologous Recombination Repair-Negative Metastatic Castration-Sensitive Prostate CancerAdvances in Therapy · 2025
12. Characterizing Diagnostic Delays in Metachromatic Leukodystrophy: A Real‐World Data ApproachJournal of Inherited Metabolic Disease · 2025
13. Effects of atidarsagene autotemcel gene therapy on peripheral nerves in late-infantile metachromatic leukodystrophyBrain · 2025
14. Safety and Tolerability of Relugolix in Combination with Abiraterone or Apalutamide for Treatment of Patients with Advanced Prostate Cancer: Data from a 52-Week Clinical TrialTargeted Oncology · 2025
15. Preservation of sexual function with Optilume—a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasiaThe Journal of Sexual Medicine · 2025
16. Surgical management and rehabilitation of ultra-low velocity bilateral multi-ligament knee injury: A case reportJournal of ISAKOS Joint Disorders & Orthopaedic Sports Medicine · 2024
17. Apalutamide for High-Risk Localized Prostate Cancer Following Radical Prostatectomy (Apa-RP)The Journal of Urology · 2024
18. Ambulatory Blood Pressure Parameters Among Men With Hypogonadism Treated With Testosterone Transdermal TherapyEndocrine Practice · 2024
19. Real-world (RW) comparison of prostate-specific antigen (PSA) response in patients with de novo metastatic castration-sensitive prostate cancer (mCSPC) treated with apalutamide (APA) versus enzalutamide (ENZ).Journal of Clinical Oncology · 2024
20. Apa-RP: Multicenter phase 2 study of apalutamide (Apa) and androgen deprivation therapy (ADT) for the treatment of high-risk localized prostate cancer (HR LPC) following radical prostatectomy (RP)—Results in Black and non-Black patients (pts).Journal of Clinical Oncology · 2024